Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells

Oncogene

Volumn 24, Issue 48, 2005, Pages 7180-7189

  Horinaka, Mano ^a,b   Yoshida, Tatsushi ^a   Shiraishi, Takumi ^a,c   Nakata, Susumu ^a   Wakada, Miki ^a   Nakanishi, Ryoko ^a   Nishino, Hoyoku ^a   Matsui, Hiroshi ^b   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Caspase; DR5; Luteolin

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR 5; LUTEOLIN; PROTEIN BCL 2; RECOMBINANT PROTEIN; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; GENE REPRESSION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; LUCIFERASES; LUTEOLIN; MALE; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 27944442079     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1208874     Document Type: Article

References (41)

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
2. Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W and Debatin KM. (1999). Proc. Natl. Acad. Sci. USA, 96, 8699-8704.
3. Dechant MJ, Fellenberg J, Scheuerpflug CG, Ewerbeck V and Debatin KM. (2004). Int. J. Cancer, 109, 661-667.
4. Elangovan V, Sekar N and Govindasamy S. (1994). Cancer Lett., 87, 107-113.
5. Fumarola C, Zerbini A and Guidotti GG. (2001). Cell Death Differ., 8, 1004-1013.
6. Gibson SB, Oyer R, Spalding AC, Anderson SM and Johnson GL. (2000). Mol. Cell Biol., 20, 205-212.
7. Greenblatt MS, Bennett WP, Hollstein M and Harris CC. (1994). Cancer Res., 54, 4855-4878.
8. Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Boiani N, Lynch DH, Smith CA, Goodwin RG and Kubin MZ. (1999). J. Immunol., 162, 2597-2605.
9. Hersey P and Zhang XD. (2001). Nat. Rev. Cancer, 1, 142-150.
10. Huang MT, Wood AW, Newmark HL, Sayer JM, Yagi H, Jerina DM and Conney AH. (1983). Carcinogenesis, 4, 1631-1637.
11. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T, Zhang H, Mountz JD, Koopman WJ, Kimberly RP and Zhou T. (2001). Nat. Med., 7, 954-960.
12. Jeng YM and Hsu HC. (2002). Cancer Lett., 181, 205-208.
13. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D and Ashkenazi A. (2001). J. Biol. Chem., 276, 46639-46646.
14. Ko WG, Kang TH, Lee SJ, Kim YC and Lee BH. (2002). Phytother. Res., 16, 295-298.
15. Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG and de Jong S. (2003). J. Pathol., 200, 327-335.
16. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D and Ashkenazi A. (2001). Nat. Med., 7, 383-385.
17. MacFarlane M, Ahmad M, Srinivasula SM, Fernandes-Alnemri T, Cohen GM and Alnemri ES. (1997). J. Biol. Chem., 272, 25417-25420.
18. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H and Aoike A. (1993). Cancer Res., 53, 1328-1331.
19. May E, Jenkins JR and May P. (1991). Oncogene, 6, 1363-1365.
20. Merfort I, Heilmann J, Hagedorn-Leweke U and Lippold BC. (1994). Pharmazie, 49, 509-511.
21. Miean KH and Mohamed S. (2001). J. Agric. Food Chem., 49, 3106-3112.
22. Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M and Sakai T. (2004). Oncogene, 23, 6261-6271.
23. Pai SI, Wu GS, Ozoren N, Wu L, Jen J, Sidransky D and El-Deiry WS. (1998). Cancer Res., 58, 3513-3518.
24. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A. (1996). J. Biol. Chem., 271, 12687-12690.
25. Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El-Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB and Dent P. (2001). Mol. Biol. Cell., 12, 2629-2645.
26. Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M and Deveraux QL. (2004). Mol. Biol. Cell., 11, 5064-5074.
27. Sheikh MS and Huang Y. (2004). Curr. Cancer Drug Targets, 4, 97-104.
28. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace Jr AJ and El-Deiry WS. (1998). Cancer Res., 58, 1593-1598.
29. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P and Ashkenazi A. (1997). Science, 277, 818-821.
30. Shimoi K, Okada H, Furugori M, Goda T, Takase S, Suzuki M, Hara Y, Yamamoto H and Kinae N. (1998). FEBS Lett., 438, 220-224.
31. Takimoto R and El-Deiry WS. (2000). Oncogene, 19, 1735-1743.
32. Ueda H, Yamazaki C and Yamazaki M. (2003). Biol. Pharm. Bull., 26, 560-563.
33. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG and Rauch CT. (1997). EMBO J., 16, 5386-5397.
34. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163.
35. Wang J, Chun HJ, Wong W, Spencer DM and Lenardo MJ. (2001). Proc. Natl. Acad. Sci. USA, 98, 13884-13888.
36. Wang S and El-Deiry WS. (2004). Cancer Res., 64, 6666-6672.
37. Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E and Bhalla K. (2000). Blood, 96, 3990-3996.
38. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA and Goodwin RG. (1995). Immunity, 3, 673-682.
39. Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G and El-Deiry WS. (1997). Nat. Genet., 17, 141-143.
40. Yamada H, Tada-Oikawa S, Uchida A and Kawanishi S. (1999). Biochem. Biophys. Res. Commun., 265, 130-133.
41. Yoshida T, Maeda A, Tani N and Sakai T. (2001). FEBS Lett., 507, 381-385.